10-Q: Globe Life Q3 2025: Strong Earnings, Share Buybacks

Globe Life Inc. reports robust Q3 2025 financial results with significant net income growth, increased premiums, and continued share repurchases.

Summary

• Net income for the nine months ended September 30, 2025, increased 10% to $895.155 million, compared to $815.566 million in the prior year.
• Diluted net income per common share rose 21% to $10.77 for the nine months ended September 30, 2025, up from $8.93 in 2024.
• Total premium income increased 5% to $3.648 billion for the nine months ended September 30, 2025, with life premium up 3% to $2.514 billion and health premium up 8% to $1.134 billion.
• Total net sales grew 6% to $661 million for the nine months ended September 30, 2025, compared to $622 million in the prior year.
• The company repurchased 4.2 million shares of common stock at a total cost of $515 million, with an average share price of $123.97, during the nine months ended September 30, 2025.
• An annual assumption review resulted in a $134.3 million net remeasurement gain before tax, driven by favorable mortality and lapse assumptions.
• Book value per share increased 27% to $69.52 at September 30, 2025, from $54.65 a year earlier, and book value per share excluding accumulated other comprehensive income (AOCI) increased 12% to $93.63.
• Net operating income as a return on equity (ROE), excluding AOCI, was 16.6% for the nine months ended September 30, 2025.

Sentiment

Score: 8

Explanation: The company reported strong financial performance with significant increases in net income, EPS, and premiums. Operational efficiencies and agent growth are positive, despite some declines in investment income and increased legal expenses. The capital structure remains robust, and the outlook for core operations is positive.

Positives

• Net income increased 10% to $895.155 million for the nine months ended September 30, 2025.
• Diluted net income per common share increased 21% to $10.77.
• Total premium increased 5% to $3.648 billion.
• Health premium increased 8% to $1.134 billion.
• Total net sales increased 6% to $661 million.
• Average producing agent count across exclusive agencies increased 4% over the prior year.
• Book value per share increased 27% to $69.52.
• Book value per share, excluding AOCI, increased 12% to $93.63.
• Life insurance underwriting margin increased $142 million (14%) due to premium growth and remeasurement gains.
• The annual assumption review resulted in a $134.3 million net remeasurement gain before tax, reflecting favorable mortality and lapse experience.
• Actual variances from expected experience for both life and health produced a $24.0 million net remeasurement gain for the three months ended September 30, 2025.
• The American Income Life Division's average producing agent count increased 3%, driven by new agent recruiting and improved retention.
• Liberty National Division's underwriting margin rose 27% to $136 million, and premium increased 5% to $292 million.
• The Family Heritage Division experienced a 13% rise in health net sales, attributed to increased agent count and productivity.
• The effective annual yield on the fixed maturity portfolio increased to 5.27% in the first nine months of 2025, up from 5.26% a year earlier.
• The net unrealized loss position in the fixed-maturity portfolio decreased from $1.7 billion at December 31, 2024, to $1.1 billion at September 30, 2025.
• The overall quality rating of the investment portfolio is A-, indicating a high-quality asset base.
• Consolidated net cash inflows from operations were $1.05 billion for the first nine months of 2025.

Negatives

• Realized losses totaled $(23.476) million for the nine months ended September 30, 2025.
• Net investment income decreased 1% to $848.796 million for the nine months ended September 30, 2025.
• Excess investment income declined 15% to $107.581 million, and per diluted common share, it decreased 7% to $1.29.
• Lower earned yields were reported on commercial mortgage loans (6.11% vs. 8.47% in prior year) and limited partnerships (7.99% vs. 8.64% in prior year).
• Insurance administrative expenses increased 5% primarily due to higher employee costs and information technology expenses.
• Stock compensation expense increased due to changes in the mix of awards and higher award values.
• Legal proceedings expenses increased to $13.365 million for the nine months ended September 30, 2025, from $5.764 million in the prior year.
• The United American Division's health underwriting margin as a percent of premium declined to 6% from 10% due to increased claims utilization from Medicare Supplement.
• Commercial paper borrowings were reduced by $88 million since year-end.

Risks

• Economic and other conditions, including inflation, immigration, geopolitical events, tariffs, and government actions, could affect lapse rates, sales, mortality, morbidity, and healthcare utilization.
• Regulatory developments, such as changes in accounting standards or governmental regulations (especially those impacting taxes and the Federal Medicare program), could affect Medicare Supplement insurance sales, claims utilization, or use.
• Market trends in the senior-aged healthcare industry, including the rise of alternatives to traditional Medicare (e.g., HMOs, managed care), could affect Medicare Supplement insurance sales.
• Interest rate changes could impact product sales, financing costs, and investment yields.
• General economic, industry sector, or individual debt issuers' financial conditions could affect the market value of owned securities or an issuer's ability to make principal and/or interest payments.
• Changes in the competitiveness of the company's products and pricing could adversely affect business.
• Litigation or regulatory actions against the company pose a risk, with inherently uncertain outcomes and potential for material adverse effects.
• Levels of administrative and operational efficiencies differing from assumptions, including increased costs from higher than anticipated inflation, could impact profitability.
• The ability to obtain timely and appropriate premium rate increases for health insurance policies from regulators is crucial for the health segment's profitability.
• Customer response to new products and marketing initiatives may not meet expectations.
• Reported amounts in financial statements are based on management estimates and judgments, which may differ from actual amounts ultimately realized.
• Compromise by a malicious actor or other event causing a loss of secure data or inaccessibility to computer and information technology systems poses a significant operational risk.
• The company's ability to attract and retain agents is critical for sales growth, particularly in exclusive agencies.
• The severity, magnitude, and impact of natural or man-made catastrophic events (e.g., pandemics, tornadoes, hurricanes, earthquakes, war, terrorism) could affect operations, personnel, commercial activity, claims levels, and product demand.
• The company's ability to access commercial paper and debt markets could be impaired if such markets become unpredictable or unstable.
• The putative securities class action and shareholder derivative lawsuits, alleging misleading statements and breach of fiduciary duty, carry inherent uncertainty and potential for adverse rulings and significant losses.
• An Equal Employment Opportunity Commission (EEOC) investigation found reasonable cause to believe sales agents were misclassified as independent contractors and discriminated against based on sex and race, potentially leading to a federal lawsuit.

Future Outlook

The company expects continued growth in recruiting activity, average producing agent count, and net sales in the Liberty National Division. It will continue to execute its existing investment strategy by seeking assets that meet quality and yield objectives while maximizing risk-adjusted, capital-adjusted returns. Dividends from subsidiaries and excess cash flows are projected to be higher in 2025 due to improved earnings and positive impacts from lower reserve increases. The company anticipates having readily available funds for 2025 and the foreseeable future to support operations and maintain target capital ratios. Share repurchases are expected to remain a primary use of excess funds if market conditions are favorable, and the company does not expect to incur losses from market value fluctuations of fixed maturities due to its ability to hold securities to maturity.

Management Comments

• Net income as a return on equity (ROE) for the nine months ended September 30, 2025, was 21.9%, and net operating income as an ROE, excluding accumulated other comprehensive income, was 16.6%.
• Total premium increased 5% over the same period in the prior year.
• Total net sales increased 6% over the same period in the prior year from $622 million in 2024 to $661 million in 2025.
• Book value per share increased 27% over the same period in the prior year from $54.65 to $69.52.
• Overall, the Company continues to see positive signs in its core operations, including sales and premium growth, and continues to achieve an operating ROE (excluding accumulated other comprehensive income) generally in the mid-teens.
• We believe this market [lower-middle to middle-income] is underserved, has significant growth potential, and provides us with a distinct competitive advantage.
• We find this flexibility [virtual recruiting, training, sales] to be enticing for new recruits as well as a driver of retention in our agency force.
• We have been focused on improving profitability and improving underwriting margin in this division [Direct to Consumer].
• The Parent Company is committed to maintaining the targeted consolidated RBC ratio at its insurance subsidiaries and has sufficient liquidity available to provide additional capital if necessary.
• If market conditions are favorable, we currently expect that share repurchases will continue to be a primary use of those funds.

Industry Context

Globe Life Inc. operates in the lower-middle to middle-income insurance market, which it identifies as underserved with significant growth potential, leveraging its extensive data and experience. The company's use of net operating income as a key performance metric aligns with common practices in the life insurance industry. The health segment faces broader industry trends, including the rise of managed care and other alternatives to traditional Medicare, which can impact Medicare Supplement sales. The company's investment strategy, primarily in investment-grade fixed maturities, is a standard approach for insurance firms managing long-term liabilities.

Comparison to Industry Standards

• The overall quality rating of the investment portfolio is A-, which is maintained despite a high ratio of BBB-rated fixed maturities relative to peers, justified by the company's ability to hold securities to maturity.
• The consolidated Company Action Level RBC ratio of 316% for 2024 is within the targeted range of 300% to 320% for 2025, indicating strong capital adequacy compared to regulatory benchmarks.
• Net operating income as an ROE, excluding accumulated other comprehensive income, of 16.6% for the nine months ended September 30, 2025, is described as 'generally in the mid-teens,' suggesting performance in line with or above typical industry expectations for a stable insurance business.

Corporate Governance

Legal Proceedings

• **City of Miami Gen. Emp. & Sanitation Emp. Ret. Trust, et al. v. Globe Life Inc., et al.**: A putative securities class action filed April 30, 2024, alleging materially false or misleading disclosures about financial performance and public statements from May 8, 2019, through April 10, 2024. Defendants' motion to dismiss was denied on September 29, 2025. The company plans to vigorously defend against the lawsuit.
• **In re Globe Life Inc. Stockholder Derivative Litigation**: A consolidated shareholder derivative suit filed November 7, 2024, and November 14, 2024, alleging breach of fiduciary duty by executives and directors for causing or permitting misleading statements. Proceedings were stayed on January 25, 2025, pending resolution of the motion to dismiss in the City of Miami Matter.
• **James E. Walker v. Gary L. Coleman, et al.**: A separate shareholder derivative lawsuit filed September 19, 2025, alleging breach of fiduciary duty (failure to prevent misconduct, insider trading) and wasting corporate assets (excessive compensation/bonuses, share repurchases at inflated prices) for the 2019-2024 period. The company intends to mount a robust defense.
• **EEOC Investigation**: On September 26, 2024, the EEOC notified Globe Life Inc. of findings of reasonable cause to believe six former/current sales agents were employees (not independent contractors) and discriminated against based on sex, and one on race. Also, reasonable cause for a pattern-or-practice of discrimination against a class of female workers. Conciliation concluded without resolution, and the EEOC may elect to file a lawsuit in federal court; the company intends to defend vigorously.

Related Party Transactions

• A guaranteed annuity contract was issued by Globe Life Inc.'s subsidiary, American Income Life Insurance Company, to fund the obligations of the American Income Life Insurance Company Collective Bargaining Agreement Employees Pension Plan.
• An additional $150 million par value and book value of Senior Notes due 06/15/2032 is held by insurance subsidiaries, which eliminates in consolidation.
• Letters of credit were issued by TMK Re, Ltd., a wholly-owned subsidiary, to secure its obligation for claims on certain policies reinsured by TMK Re, Ltd. that were sold by other Globe Life insurance subsidiaries.

Stakeholder Impact

• **Shareholders**: Positive impact from increased net income, diluted EPS, book value per share, and ongoing share repurchase program. Potential negative impact from the inherent uncertainty and potential adverse outcomes of ongoing securities class action and shareholder derivative lawsuits. Quarterly dividends provide direct returns.
• **Employees/Agents**: Positive impact from increased average producing agent count and investments in technology (CRM, virtual tools) to enhance productivity and retention. Potential negative impact from the EEOC investigation regarding worker classification and discrimination allegations, which could lead to significant legal and operational changes.
• **Customers**: Benefit from new technology implemented to enhance the underwriting process and create a seamless customer experience. The company's focus on basic protection life and health insurance products aims to provide financial security.
• **Creditors**: The company maintains strong liquidity and capital resources, and the Parent Company is in full compliance with all debt covenants, indicating a stable financial position for creditors.
• **Regulators**: Subject to ongoing regulatory scrutiny, including the EEOC investigation and compliance with NAIC Risk-Based Capital (RBC) ratios, which the company targets to maintain at adequate levels.

Next Steps

• Continue to focus on growing and strengthening the agency force, specifically through emphasis on agency middle-management growth and additional agency openings.
• Implement incentive and retention programs to further increase the number of producing agents in the Family Heritage Division.
• Continue to execute on the existing investment strategy by seeking to invest in assets that satisfy quality and other objectives, while maximizing risk-adjusted, capital-adjusted return.
• Maintain statutory capital within insurance subsidiaries at levels necessary to support current ratings, targeting a consolidated Company Action Level RBC ratio of 300% to 320%.
• Determine the best use of excess cash flow, with share repurchases expected to be a primary use if market conditions are favorable.
• Implement ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, for annual periods beginning January 1, 2025.
• Evaluate ASU No. 2024-03, Income StatementReporting Comprehensive IncomeExpense Disaggregation Disclosures (Subtopic 220-40), for annual periods beginning January 1, 2027.
• Evaluate ASU No. 2025-06, IntangiblesGoodwill and OtherInternal-Use Software (Subtopic 350-40), for annual periods beginning January 1, 2028.
• Vigorously defend against the putative securities class action and shareholder derivative lawsuits.

Key Dates

Recommendation

The company demonstrates strong financial health with significant year-over-year growth in net income, diluted EPS, and total premiums. The increase in book value per share and consistent share repurchase program indicate effective capital management and shareholder returns. While there are ongoing legal proceedings and some declines in investment income yields, the core insurance operations are robust, and the company maintains strong liquidity and capital adequacy, making it an attractive investment.

Keywords

Life Insurance, Health Insurance, SEC Filing, 10-Q, Financial Results, Earnings, Premium Growth, Share Repurchase, Investment Portfolio, Underwriting Margin, Policy Liabilities, Mortgage Loans, Fixed Maturities, Commercial Paper, Credit Facility, Legal Proceedings, Corporate Governance, Risk Factors, Insurance Industry, Globe Life Inc.